Skip to main content
. Author manuscript; available in PMC: 2024 Jun 8.
Published in final edited form as: J Med Chem. 2023 May 17;66(11):7454–7474. doi: 10.1021/acs.jmedchem.3c00176

Table 3.

BTK Binding and Target Engagement of BTK and CRBN in HEK293 Cells

Compound DC50 (nM)
Ramos cellsa
BTK Kd (nM)b BTK IC50 (nM)c CRBN IC50 (nM)c Ternary Complex Formationd
GDC-0853 0.35 12.1 ± 1
(1.1)
NDe
Pomalidomide NDe NDe 83 ± 10
(0.8)
PTD10 0.5 ± 0.2 2.28 97 ± 11
(1.9)
107 ± 19
(1.0)
100%
PTD13 >3,000 0.86 320 ± 30
(1.4)
7000 ± 700
(1.0)
0
PTD15 113 ± 20 107 3212 ± 208
(1.3)
5000 ± 300
(0.5)
~75%
a

DC50 values are taken from Tables 1 and 2.

b

Determined by TR-FRET at 37 °C.

c

Target engagement in cells at 37 °C. Numbers in parentheses are the Hill slopes.

d

Maximum ternary complex formation setting the BRET ratio for PTD10 at 100%.

e

ND, not determined.